{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:10:17Z","timestamp":1790003417182,"version":"4.0.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"The Danish Heart Association and Herlev and Gentofte Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>The physiological role of lipoprotein(a) is unclear; however, lipoprotein(a) may play a role in hemostasis and wound healing. We tested the hypothesis that high lipoprotein(a) concentrations are associated with low risk of major bleeding in the brain and airways both observationally and causally (from human genetics).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We examined 109169 individuals from the Copenhagen City Heart Study and the Copenhagen General Population study, 2 similar prospective studies conducted in the Danish general population. Individuals had information on plasma lipoprotein(a) concentrations (n = 59980), LPA kringle-IV type 2 (KIV-2) number of repeats (n = 98965), and\/or LPA single-nucleotide polymorphism rs10455872 associated with high lipoprotein(a) concentrations (n = 109 169), and information on hospital contacts or death due to major bleeding in brain and airways from registers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Using extreme phenotypes or genotypes, the multifactorially adjusted hazard ratio for major bleeding in the brain and airways was 0.84 (95%CI: 0.71\u20130.99) for lipoprotein(a), &amp;gt;800 mg\/L vs &amp;lt;110 mg\/L; 0.83 (0.73\u20130.96) for KIV-2, &amp;lt;24 vs &amp;gt;35 number of repeats; and 0.89 (0.81\u20130.97) for rs10455872 carriers (heterozygotes + homozygotes) vs noncarriers. The corresponding hazard ratios were 0.89 (0.82\u20130.98) for heterozygotes and 0.59 (0.36\u20130.98) for homozygotes separately vs rs10455872 noncarriers. Also, for a 1 standard deviation higher lipoprotein(a) (= 310 mg\/L), the hazard ratio for major bleeding in the brain and airways was 0.95 (95%CI: 0.91\u20131.00) observationally, 0.89 (0.80\u20130.98) causally based on LPA KIV-2 number of repeats, and 0.94 (0.87\u20131.02) causally based on LPA rs10455872.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>High lipoprotein(a) concentrations were associated with lower risk of major bleeding in the brain and airways observationally and causally. This indicates that lipoprotein(a) may play a role in hemostasis and wound healing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1373\/clinchem.2017.276931","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T23:14:06Z","timestamp":1504739646000},"page":"1714-1723","source":"Crossref","is-referenced-by-count":41,"title":["High Lipoprotein(a) and Low Risk of Major Bleeding in Brain and Airways in the General Population: a Mendelian Randomization Study"],"prefix":"10.1093","volume":"63","author":[{"given":"Anne","family":"Langsted","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry and"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia R","family":"Kamstrup","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry and"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry and"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Denmark"},{"name":"The Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"2020022606143658300_B1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp (a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"2020022606143658300_B2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"2020022606143658300_B3","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein (a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"2020022606143658300_B4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/ATVBAHA.112.248765","article-title":"Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis","volume":"32","author":"Kamstrup","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020022606143658300_B5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"2020022606143658300_B6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2020022606143658300_B7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein (a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2020022606143658300_B8","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"2020022606143658300_B9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein (a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J Intern Med"},{"key":"2020022606143658300_B10","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet"},{"key":"2020022606143658300_B11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"2020022606143658300_B12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"2020022606143658300_B13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2015.07.045","article-title":"How does elevated lipoprotein(a) cause aortic valve stenosis?","volume":"66","author":"Nordestgaard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2020022606143658300_B14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/330113a0","article-title":"Plasma lipoproteins: teaching old dogmas new tricks","volume":"330","author":"Brown","year":"1987","journal-title":"Nature"},{"key":"2020022606143658300_B15","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","article-title":"Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis","volume":"98","author":"Caplice","year":"2001","journal-title":"Blood"},{"key":"2020022606143658300_B16","first-page":"2753","article-title":"Lipoprotein(a)","volume-title":"The metabolic and molecular bases of inherited disease","author":"Utermann","year":"2001","edition":"8th Ed"},{"key":"2020022606143658300_B17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clinbiochem.2003.12.007","article-title":"Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models","volume":"37","author":"Boffa","year":"2004","journal-title":"Clin Biochem"},{"key":"2020022606143658300_B18","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/jc.2015-1096","article-title":"Elevated lipoprotein(a) does not cause low-grade inflammation despite causal association with aortic valve stenosis and myocardial infarction: a study of 100,578 individuals from the general population","volume":"100","author":"Langsted","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022606143658300_B19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"2020022606143658300_B20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2213-8587(13)70064-0","article-title":"Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study","volume":"1","author":"Kamstrup","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020022606143658300_B21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"2020022606143658300_B22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1749-6632.2001.tb03514.x","article-title":"Inhibition of fibrinolysis by lipoprotein(a)","volume":"936","author":"Angles-Cano","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"2020022606143658300_B23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1055\/s-0037-1616056","article-title":"The kringle V-protease domain is a fibrinogen binding region within apo(a)","volume":"86","author":"Xue","year":"2001","journal-title":"Thromb Haemost"},{"key":"2020022606143658300_B24","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.ATV.0000021144.87870.C8","article-title":"Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody","volume":"22","author":"Kang","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020022606143658300_B25","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"J Biol Chem"},{"key":"2020022606143658300_B26","first-page":"1754","article-title":"Plasminogen receptors: the sine qua non of cell surface plasminogen activation","volume":"10","author":"Miles","year":"2005","journal-title":"Front Biosci"},{"key":"2020022606143658300_B27","doi-asserted-by":"crossref","first-page":"15777","DOI":"10.1021\/bi00048a023","article-title":"Analysis of the proteolytic activity of a recombinant form of apolipoprotein (a)","volume":"34","author":"Gabel","year":"1995","journal-title":"Biochemistry"},{"key":"2020022606143658300_B28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/339301a0","article-title":"A potential basis for the thrombotic risks associated with lipoprotein(a)","volume":"339","author":"Miles","year":"1989","journal-title":"Nature"},{"key":"2020022606143658300_B29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1194\/jlr.M036566","article-title":"Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)","volume":"55","author":"Romagnuolo","year":"2014","journal-title":"J Lipid Res"},{"key":"2020022606143658300_B30","doi-asserted-by":"crossref","first-page":"923289","DOI":"10.1155\/2012\/923289","article-title":"Lipoprotein(a): cellular effects and molecular mechanisms","volume":"2012","author":"Riches","year":"2012","journal-title":"Cholesterol"},{"key":"2020022606143658300_B31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1538-7836.2006.01903.x","article-title":"Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis","volume":"4","author":"Undas","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2020022606143658300_B32","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.jprot.2011.07.008","article-title":"Proteomics of lipoprotein(a) identifies a protein complement associated with response to wounding","volume":"74","author":"von","year":"2011","journal-title":"J Proteomics"},{"key":"2020022606143658300_B33","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.thromres.2012.11.032","article-title":"Inverse association between serum lipoprotein(a) and cerebral hemorrhage in the Japanese population","volume":"131","author":"Ishikawa","year":"2013","journal-title":"Thromb Res"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/11\/1714\/32647585\/clinchem1714.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/11\/1714\/32647585\/clinchem1714.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T06:18:58Z","timestamp":1659421138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/63\/11\/1714\/5612695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,1]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2017.276931","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,1]]},"published":{"date-parts":[[2017,11,1]]}}}